Simple Wastewater Preparation Protocol Applied to Monitor the Emergence of the Omicron 21L/BA.2 Variant by Genome Sequencing.
Nathalie WurtzMaelle BoussierLouis SouvilleGwilherm PenantAlexandre LacostePhilippe ColsonBernard La ScolaSarah AherfiPublished in: Viruses (2023)
Detecting and monitoring viruses in wastewater samples have been reported as useful ways of tracking SARS-CoV-2 epidemic trends. However, there is currently no unanimously recognised method of processing samples to identify and quantify SARS-CoV-2 variants in wastewater. We aimed to implement a method that was as simple as possible in order to be used universally. In a study performed between January 2022 and June 2022 in the city of Marseille, France, we first evaluated the impact of the sample preservation strategy. We then compared ultracentrifugation to ultrafiltration and several steps of filtration to determine the optimal approach for virus concentration. As a proof-of-concept, the definitive protocol was applied to next-generation sequencing of SARS-CoV-2 in wastewater to monitor the emergence of the Omicron variant in the city. For sewage water to be processed in the week following the sampling, storage at +4 °C is sufficient, with less than 1 Ct loss. Filtration with a 5 µm syringe filter, then with a 0.8 µm filtration unit, followed by ultrafiltration was the optimal protocol, leading to an average increase of 3.24 Ct when the starting Ct was on average 38 in the wastewater. This made it possible to observe the emergence of the Omicron 21L/BA.2 variant after Omicron 21K/BA.1 by genome sequencing over a period ranging from 20 February to 10 April 2022 in agreement with observations based on patient data. To conclude, by using a simple method requiring only basic filters and a centrifuge as equipment, it is possible to accurately track the relative incidence rates and the emergence of SARS-CoV-2 variants based on sewage samples.
Keyphrases
- sars cov
- wastewater treatment
- respiratory syndrome coronavirus
- anaerobic digestion
- image quality
- computed tomography
- randomized controlled trial
- copy number
- dual energy
- contrast enhanced
- antibiotic resistance genes
- positron emission tomography
- genome wide
- single cell
- magnetic resonance imaging
- squamous cell carcinoma
- high resolution
- mass spectrometry
- radiation therapy
- electronic health record
- clinical trial
- molecularly imprinted
- cell free
- artificial intelligence
- rectal cancer
- solid phase extraction
- circulating tumor cells